Log in

Start free trial
Lack of Utility Evidence Still Hampers Adoption of Pharmacogenomic Testing: Benefits Seen in the Field of Psychiatry

Lack of Utility Evidence Still Hampers Adoption of Pharmacogenomic Testing: Benefits Seen in the Field of Psychiatry

by | Jul 9, 2018 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Inside the Diagnostics Industry-dtet

From - Diagnostic Testing & Emerging Technologies
For years it had been hoped that pharmacogenetic (PGx) testing would be a leading application for personalized medicine…


. . . read more

This content is for Paid Members only.
Register
Already a member? Log in here
New Study Provides Most Comprehensive Overview of Genetic Test Development, Usage and Spending

New Study Provides Most Comprehensive Overview of Genetic Test Development, Usage and Spending

by | Jun 11, 2018 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, Inside the Diagnostics Industry-dtet

From - Diagnostic Testing & Emerging Technologies
As might be expected, there has been rapid growth in genetic test availability and spending on these tests since 2014. But, comprehensive new collaborative analysis conducted by…


. . . read more

This content is for Paid Members only.
Register
Already a member? Log in here